VILOBELIMAB

UNII:	F5T0RF9ZJA
Formula:
Preferred Substance Name:	VILOBELIMAB

2250440-41-4
CACP 29
CACP29
IFX-1
IMMUNOGLOBULIN G4, ANTI-(HUMAN COMPLEMENT C5A) (HUMAN-MUS MUSCULUS MONOCLONAL IFX-1 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL IFX-1 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS C5 (COMPLEMENT 5) ANAPHYLATOXIN (C5A, C5 PR678-751)), CHIMERIC MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN CHIMERIC (1-446) (VH (MUS MUSCULUS IGHV1-61*01 (81.6%)-(IGHD)-IGHJ3*01 (92.9%)/HOMO SAPIENS IGHV1-46*01 (62.2%)-(IGHD)-IGHJ4*01 (92.9%)) (8.8.13) (1-119)-HOMO SAPIENS IGHG4*01 (CH1 (120-217), HINGE 1-12 (218-229), CH2 (230-339), CH3 (340-444), CHS (445-446)) (120-446)), (133-218')-DISULFIDE WITH KAPPA LIGHT CHAIN CHIMERIC (1'-218') (V-KAPPA (MUS MUSCULUS IGKV3-4*01 (98.0%)-IGKJ2*01 (100%)/HOMO SAPIENSIGKV3D-11*02 (69.1%)-IGKJ2*01 (91.7%)) (10.3.9) (1'-111')-HOMO SAPIENSIGKC*01 (100%), KM3 A45.1 (157), V101 (195) (112'-218'))DIMER (225-225'':228-228'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA
VILOBELIMAB [INN]
VILOBELIMAB [USAN]
VILOBELIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

VILOBELIMAB

Synonyms and Mappings

Resources